Conversations in Breast Cancer Screening: An Exploration of Age, Density, and Emerging Technologies
DOI:
https://doi.org/10.58931/cwht.2024.1211Abstract
Breast Cancer remains a significant burden in Canada, reflecting global patterns as one of the most common cancers affecting women. In 2023, it was estimated that 26% of all new cancer cases among Canadian women were attributed to breast cancer, contributing to 13% of all cancer deaths in this group. Recent advancements in both detection and treatment of breast cancer have significantly improved cure rates, particularly when breast cancer is detected early. Early-stage breast cancer detected through screening can have a 5-year survival rate of 99%. Thus, the quest for early detection through effective and economical screening initiatives is a critical component in minimizing the burden of disease and reducing breast cancer-related mortality.
However, ongoing dialogue continues within the medical community regarding the optimal timing of screening initiation for women at average risk. Discussion about the appropriate age to discontinue screening is an evolving topic. This conversation is complex and multifaceted, involving careful consideration of the intricate balance between the benefits of early detection, economic implications of population screening, and potential harms such as overdiagnosis and the psychological impact of false positives. Current Canadian guidelines, last updated in 2018, recommended mammography screening every 2–3 years for women aged 50–74 years, reflecting an expert consensus that considers both scientific evidence and population health needs. These guidelines are under revision with an update expected in 2024, while other major organizations have recently published new recommendations, reflecting the value of early detection at a younger age in the effort to minimize cancer deaths.
Additionally, the efficacy of mammography alone as a screening modality in women with dense breast tissue, who constitute up to 43% of the screening population, has come into question.7,8 This challenge has catalyzed discussion around recommended supplementary screening modalities to improve cancer detection rates in women with dense breast tissue.9
This article explores the ongoing discourse on breast cancer screening recommendations for average-risk women, including the age at which to initiate and stop screening, imaging modalities, and emerging technologies.
References
Canadian Cancer Statistics Advisory Committee. Canadian Cancer Statistics 2023 Toronto, ON: Canadian Cancer Society; 2023 [cited 2024 March 24].
Alsammak M, Khattabi M. Breast cancer screening a literature review. International Journal Of Community Medicine And Public Health. 2023;10:4473-4479. doi:10.18203/2394-6040.ijcmph20233497
Tippannavar S, S D Y, Shivakumar G, Madappa E. Early detection of breast cancer using versatile techniques -a study. Journal of Innovative Image Processing. 2023;5:270-289. doi:10.36548/jiip.2023.3.004
Thériault G, Reynolds DL, Grad R, Dickinson JA, Singh H, Szafran O, et al. Debunking myths about screening: How to screen more judiciously. Can Fam Physician. 2023;69(11):767-771. doi:10.46747/cfp.6911767
Klarenbach S, Sims-Jones N, Lewin G, Singh H, Thériault G, Tonelli M, et al. Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer. Cmaj. 2018;190(49):E1441-e1451. doi:10.1503/cmaj.180463
Yong-Hing CJ, Gordon PB, Appavoo S, Fitzgerald SR, Seely JM. Addressing misinformation about the Canadian breast screening guidelines. Can Assoc Radiol J. 2023;74(2):388-397. doi:10.1177/08465371221120798
Wilkinson AN. Breast density notification: Are family doctors prepared to counsel patients on risks and management? Can Fam Physician. 2023;69(11):748-750. doi:10.46747/cfp.6911748
Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356(3):227-236. doi:10.1056/NEJMoa062790
Veenhuizen SGA, de Lange SV, Bakker MF, Pijnappel RM, Mann RM, Monninkhof EM, et al. Supplemental breast MRI for women with extremely dense breasts: results of the second screening round of the DENSE trial. Radiology. 2021;299(2):278-286. doi:10.1148/radiol.2021203633
Ren W, Chen M, Qiao Y, Zhao F. Global guidelines for breast cancer screening: a systematic review. Breast. 2022;64:85-99. doi:10.1016/j.breast.2022.04.003
American Cancer Society. ACS Breast Cancer Screening Guidelines 2023 [cited 2024 March 31]. Available from: https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html.
Monticciolo DL, Malak SF, Friedewald SM, Eby PR, Newell MS, Moy L, et al. Breast cancer screening recommendations inclusive of all women at average risk: update from the ACR and Society of Breast Imaging. J Am Coll Radiol. 2021;18(9):1280-1288. doi:10.1016/j.jacr.2021.04.021
Wilkinson AN, Ellison LF, Billette JM, Seely JM. Impact of breast cancer screening on 10-year net survival in Canadian women age 40-49 Years. J Clin Oncol. 2023;41(29):4669-4677. doi:10.1200/jco.23.00348
Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, et al. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019;69(3):184-210. doi:10.3322/caac.21557
Burnside ES, Trentham-Dietz A, Shafer CM, Hampton JM, Alagoz O, Cox JR, et al. Age-based versus risk-based mammography screening in women 40-49 Years old: a cross-sectional study. Radiology. 2019;292(2):321-328. doi:10.1148/radiol.2019181651
Yaffe MJ, Jong RA, Pritchard KI. Breast cancer screening: beyond mortality. J Breast Imaging. 2019;1(3):161-165. doi:10.1093/jbi/wbz038
De Albeniz XG, Hernán M, Logan R, Price M, Hsu J. 1644P - Continuation of annual screening mammograms and breast-cancer mortality in women over 70. Annals of Oncology. 2019;30:v675-v676. doi:https://doi.org/10.1093/annonc/mdz263.016
Baines CJ, To T, Miller AB. Revised estimates of overdiagnosis from the Canadian National Breast Screening Study. Prev Med. 2016;90:66-71. doi:10.1016/j.ypmed.2016.06.033
Esserman LJ. The WISDOM Study: breaking the deadlock in the breast cancer screening debate. NPJ Breast Cancer. 2017;3:34. doi:10.1038/s41523-017-0035-5
Wilkinson AN, Billette JM, Ellison LF, Killip MA, Islam N, Seely JM. The impact of organised screening programs on breast cancer stage at diagnosis for Canadian women aged 40-49 and 50-59. Curr Oncol. 2022;29(8):5627-5643. doi:10.3390/curroncol29080444
Mainiero MB, Lourenco A, Mahoney MC, Newell MS, Bailey L, Barke LD, et al. ACR appropriateness criteria breast cancer screening. J Am Coll Radiol. 2013;10(1):11-14. doi:10.1016/j.jacr.2012.09.036
Lee CS, Lewin A, Reig B, Heacock L, Gao Y, Heller S, et al. Women 75 years old or older: to screen or not to screen? Radiographics. 2023;43(5):e220166. doi:10.1148/rg.220166
Mann RM, Athanasiou A, Baltzer PAT, Camps-Herrero J, Clauser P, Fallenberg EM, et al. Breast cancer screening in women with extremely dense breasts recommendations of the European Society of Breast Imaging (EUSOBI). Eur Radiol. 2022;32(6):4036-4045. doi:10.1007/s00330-022-08617-6
Emaus MJ, Bakker MF, Peeters PH, Loo CE, Mann RM, de Jong MD, et al. MR imaging as an additional screening modality for the detection of breast cancer in women aged 50-75 years with extremely dense breasts: the DENSE trial study design. Radiology. 2015;277(2):527-537. doi:10.1148/radiol.2015141827
Barba D, León-Sosa A, Lugo P, Suquillo D, Torres F, Surre F, et al. Breast cancer, screening and diagnostic tools: All you need to know. Crit Rev Oncol Hematol.2021;157:103174. doi:10.1016/j.critrevonc.2020.103174
Practice CoG. Management of women with dense breasts diagnosed by mammography 2015 [updated 2017; cited 2024 March 31]. Available from: https://www.acog.org/clinical/clinical-guidance/committeeopinion/articles/2015/03/management-of-womenwith-dense-breasts-diagnosed-by-mammography.
Hussein H, Abbas E, Keshavarzi S, Fazelzad R, Bukhanov K, Kulkarni S, et al. Supplemental breast cancer screening in women with dense breasts and negative mammography: a systematic review and meta-analysis. Radiology. 2023;306(3):e221785. doi:10.1148/radiol.221785
Larsen M, Olstad CF, Koch HW, Martiniussen MA, Hoff SR, Lund-Hanssen H, et al. AI risk score on screening mammograms preceding breast cancer diagnosis. Radiology. 2023;309(1):e230989. doi:10.1148/radiol.230989
Dey S, Roychoudhury R, Malakar S, Sarkar R. Screening of breast cancer from thermogram images by edge detection aided deep transfer learning model. Multimed Tools Appl. 2022;81(7):9331-9349.doi:10.1007/s11042-021-11477-9
Singh A, Bhat V, Sudhakar S, Namachivayam A, Gangadharan C, Pulchan C, et al. Multicentric study to evaluate the effectiveness of Thermalytix as compared with standard screening modalities in subjects who show possible symptoms of suspected breast cancer. BMJ Open. 2021;11(10):e052098. doi:10.1136/bmjopen-2021-052098
Kennedy DA, Lee T, Seely D. A comparative review of thermography as a breast cancer screening technique. Integr Cancer Ther. 2009;8(1):9-16. doi:10.1177/1534735408326171
